Caffeine Focus Randomized Trial: What the Evidence Says

Quick Answer

Caffeine Focus Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In today's technology-driven world, the pursuit of enhanced productivity has increased the demand for effective strategies to mitigate cognitive dysfunction and support optimal mental performance. [Thomas Jestin V. (2026); evidence level 2]
• These compounds may support alertness, attention, learning, and memory, while generally lacking the significant adverse effects associated with traditional stimulants. [Thomas Jestin V. (2026); evidence level 2]
• The 2018 International Olympic Committee (IOC) reported that caffeine is among the five nutritional supplements whose positive effects on athletic performance are supported by scientific evidence. [Bingol Diedhiou Azize (2026); evidence level 2]
• Caffeine is metabolized by the CYP1A2 enzyme, which is found in the liver and is responsible for approximately 95% of the cytochrome P450 family. [Bingol Diedhiou Azize (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For caffeine focus randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Thomas Jestin V. (2026). A full-spectrum aqueous extract of black cardamom ( Amomum subulatum ) improves focus/alertness and executive function: a randomized, double-blinded, placebo- and active-controlled, comparative study in healthy working-class participants. DOI: 10.3389/fnins.2026.1786880. PMCID: PMC13100988. PMID: 42027681. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13100988/
• Bingol Diedhiou Azize (2026). Comparative effects of caffeine and paraxanthine on rowing performance and sleep quality: a randomized crossover study. DOI: 10.1080/15502783.2026.2650339. PMCID: PMC13045172. PMID: 41918248. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13045172/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.